Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,308.00
Bid: 12,308.00
Ask: 12,312.00
Change: 190.00 (1.57%)
Spread: 4.00 (0.032%)
Open: 12,244.00
High: 12,314.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks Drop On Rising Virus Cases; Airlines Fall

Mon, 26th Oct 2020 08:49

(Alliance News) - Stock prices in London opened lower on Monday amid a rise in Covid-19 cases, while travel stocks fell after German carrier Lufthansa warned of a worsening outlook for the sector.

Investor sentiment was hurt by a surge of coronavirus cases across the US and Europe. The new wave already had forced governments in several countries including the UK, Germany and France to reimpose tough restrictions to prevent the disease from spreading.

Spain declared a national state of emergency on Sunday to tackle a second coronavirus wave as the World Health Organization reported a third straight day of record new infections across the world.

The WHO has warned that some countries are on a "dangerous track", with too many witnessing an exponential increase in cases, and called on countries to take further action to curb the spread of the disease.

In total, the UN agency's figures showed that 465,319 cases were declared on Saturday alone, half of them in Europe.

Italy has ordered the closure of theatres, cinemas and gyms and said bars and restaurants must shut early.

In the US, a record of nearly 80,000 new Covid-19 infections over the course of a day were reported on Friday, according to figures from Johns Hopkins University.

The virus has now claimed the lives of 1.1 million people and infected more than 42 million globally.

The FTSE 100 index was down 38.67 points, or 0.7%, at 5,821.61. The FTSE 250 was down 159.55 points, or 0.9%, at 17,950.02. The AIM All-Share was 0.2% lower at 978.42.

The Cboe UK 100 was down 0.9% at 576.68. The Cboe 250 was down 0.7% at 15,218.56 and the Cboe Small Companies down 0.1% at 9,650.09.

In Paris the CAC 40 was down 1.2%, while the DAX 30 in Frankfurt was down 2.1%.

"Another spike in Covid-19 cases both in the US and Europe has dented sentiment. Despite some positive developments from the likes of Gilead and AstraZeneca on the search for a vaccine, the immediate damage is already being felt in the real economy, with unemployment and the containment of the virus becoming [US] election focal points," Interactive Investor's Richard Hunter said.

In the FTSE 100, AstraZeneca was up 0.9% after the Anglo-Swedish drugmaker late Friday said clinical trials for its AZD1222 coronavirus vaccine, being developed alongside Oxford University, have been resumed around the world, as regulators in the US, UK, Brazil, South Africa and Japan confirmed that it is safe to do so.

The US Food & Drug Administration authorised the restart of the trials in the US, after they had resumed in other countries in recent weeks, following the review of all safety data from trials in other regions.

At the other end of London large caps, British Airways parent International Consolidated Airlines as down 2.8% on fresh worries over Covid-19 restrictions.

Sentiment towards the travel sector was hurt after German airline Deutsche Lufthansa said it was planning further cost-cutting measures including reducing its fleet and grounding additional aircraft due to ongoing travel restrictions, the company's board wrote in a letter to staff on Sunday.

Lufthansa shares were down 4.7% in Frankfurt.

Midcap travel stocks Tui and easyJet were down 6.1% and 1.9% respectively. Ryanair Holdings was down 1.1%.

Royal Dutch Shell 'A' and 'B' shares were down 2.2% and 2.1% respectively and BP was down 0.7%. The oil major was tracking spot oil prices lower.

Brent oil was trading at USD40.88 a barrel on Monday morning, down sharply from USD42.25 late Friday.

Warring factions in Libya signed a countrywide ceasefire on Friday brokered by the United Nations. The ceasefire is poised to lead to more Libyan oil supply to the market at a time when demand is weak.

"The chief culprit was Libya, where the national oil body lifted all its force majeure's and [will] ramp up production to 1 million barrels per day in the next few weeks," said Oanda Markets analyst Jeffery Halley.

"The return of just one million barrels per day of extra production to the world market has sent oil into a tailspin. It highlights how fragile sentiment is to the supply/demand balance of oil in international markets. A double-dip recession in Europe will add to the demand concerns," Halley added.

The Japanese Nikkei 225 index closed down 0.1%. In mainland China, the Shanghai Composite closed down 0.9%. Financial markets in Hong Kong were closed for a local holiday, the Chung Yeung festival.

The pound was quoted at USD1.3015 Monday morning, down from USD1.3050 at the London equities close Friday.

The euro was priced at USD1.1828, lower from USD1.1840. Against the yen, the dollar was trading at JPY104.87, flat from JPY104.80.

Elsewhere in commodities, gold was quoted at USD1,897.25 an ounce, lower from USD1,900.50.

The economic events calendar on Monday has US new home sales at 1500 GMT.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.